Mural Oncology (MURA) Expected to Announce Earnings on Tuesday

Mural Oncology (NASDAQ:MURA) is expected to be releasing its earnings data before the market opens on Tuesday, March 25th. Analysts expect Mural Oncology to post earnings of ($1.98) per share for the quarter.

Mural Oncology (NASDAQ:MURA) last released its quarterly earnings results on Tuesday, March 11th. The company reported ($2.01) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($1.96) by ($0.05). During the same period in the prior year, the company earned ($3.57) EPS. On average, analysts expect Mural Oncology to post $-8 EPS for the current fiscal year and $-5 EPS for the next fiscal year.

Mural Oncology Stock Performance

Mural Oncology stock opened at $3.85 on Monday. Mural Oncology has a fifty-two week low of $2.87 and a fifty-two week high of $5.12. The stock’s 50 day simple moving average is $3.91 and its two-hundred day simple moving average is $3.62. The stock has a market cap of $66.33 million, a price-to-earnings ratio of -0.42 and a beta of 3.66.

Analyst Ratings Changes

Separately, HC Wainwright restated a “buy” rating and set a $18.00 price target on shares of Mural Oncology in a research report on Wednesday, March 12th.

About Mural Oncology

Mural Oncology plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab.